Page 4 - Phase Labs News Today

ProPhase Labs (NASDAQ:PRPH) CEO Ted Karkus joins Natalie Stoberman in the Proactive studio to break down how the company has transformed in the biotech...

Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D. - read this article along with other careers information, tips and advice on BioSpace

GARDEN CITY, NY, Oct. 17, 2022 -- ProPhase Labs, Inc. , a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly owned subsidiary, Nebula... | October 17, 2022

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $9.77 and traded as high as $10.68. ProPhase Labs shares last traded at $10.26, with a volume of 51,993 shares. Analysts Set New Price Targets A number […]

GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...

GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...

In this article, we discuss 10 stocks that are gaining after announcing share buybacks.

Garden City, NY, July 19, 2022 -- ProPhase Labs, Inc. , a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday, July 21, 2022, at 11:30 a.m.... | July 19, 2022

FCX fell to a new low as copper continued to fall. COWN rallied on a report of a potential takeover. PRPH set a new 52-week high. STLA fell on worries about a semiconductor shortage.

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology - read this article along with other careers information, tips and advice on BioSpace